Indications for: DUREZOL
Post-op inflammation and pain associated with ocular surgery. Endogenous anterior uveitis.
Post-op inflammation/pain: 1 drop into affected eye(s) 4 times daily beginning 24hrs after surgery, continue for 2 weeks post-op, followed by 2 times daily for a week, then taper based on response. Uveitis: 1 drop into affected eye(s) 4 times daily for 14 days, followed by tapering as clinically indicated.
Ocular fungal, viral, or mycobacterial infections.
Do not administer while wearing contacts. Corneal or scleral thinning. Glaucoma. History of herpes simplex. May mask or exacerbate ocular infections. Monitor IOP and for secondary infections in prolonged therapy (>10 days). Pregnancy (Cat.C). Nursing mothers.
Corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells and flare, conjunctival edema, blepharitis, blurred vision, eye irritation, headache, iritis, limbal hyperemia, punctate keratitis, uveitis; cataract formation, corneal perforation. Prolonged use may increase: IOP, optic nerve damage, visual acuity and field defects. May delay healing and increase bleb formation after cataract surgery.
Generic Drug Availability: